secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2022-02-03T23:59:59+00:00
Accession:  0001295947-22-000007
Event type: earnings
Sentiment:  positive
Materiality: 0.78
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Q3 revenue $274.5M (+14.9% YoY), EPS $0.99 (+22.2%); raises FY22 outlook
--------------------------------------------------------------------------------

- Revenue $274.5M, up 14.9% YoY; organic growth 8.8% excluding currency and Akorn acquisition.
- Diluted EPS $0.99, up 22.2% YoY; FY22 adjusted diluted EPS guidance raised to $4.00-$4.04.
- Non-GAAP free cash flow $64.1M in Q3 vs $43.5M prior year; FY22 free cash flow guidance raised to $250M+.
- North America OTC segment $240.9M (+14.4%); International OTC $33.6M (+19.3% record).
- Paid down $70M debt in Q3; net debt ~$1.5B, covenant leverage ratio 3.9x.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594722000007/0001295947-22-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594722000007/pbh-20220203.htm
  HTML page:      https://secwatch.observer/filing/0001295947-22-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer